Literature DB >> 14764037

The risk of nodal metastasis in early adenocarcinoma of the uterine cervix.

J Balega1, H Michael, J Hurteau, D H Moore, J Santiesteban, G P Sutton, K Y Look.   

Abstract

A functional and widely accepted definition of microinvasive cervical adenocarcinoma remains elusive. The purpose of this study was to determine at which depth of invasion the likelihood of lymph node metastasis or disease recurrence was so small that conservative surgery could be considered appropriate. Charts of patients with adenocarcinoma of the cervix (ACC) who underwent radical hysterectomy and pelvic lymphadenectomy (n = 98) at Indiana University Medical Center from 1987 to 1998 were retrospectively reviewed. Patients with stage IA1-IB1 lesions were included in the study. Patients treated with preoperative radiotherapy were excluded. Pathologic parameters evaluated included histologic type, depth of stromal invasion (DOI), and the presence of lymphatic vascular space invasion, or lymph node metastases. The patient median age was 39 years (20-65). The median time of follow-up was 30 months (4-124). Lymph node metastases were found in ten patients and 11 developed recurrences. The precise DOI could be measured in 84 patients. Of the 48 patients with cancers with a DOI </= 5 mm, none had involved parametria or nodes; whereas eight of the 36 with a DOI > 5 mm had nodal metastases (P = 0.00069). None of these 48 patients with a tumor DOI </= 5 mm developed a recurrence whereas six of the 36 patients with a tumor DOI > 5 mm developed recurrent disease (P = 0.0048). The risk of nodal metastases and recurrence is so low in patients with ACC and DOI </= 5 mm that for patients with such depth documented on conization with negative margins pelvic lymphadenectomy may be omitted.

Entities:  

Mesh:

Year:  2004        PMID: 14764037     DOI: 10.1111/j.1048-891x.2004.14079.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  5 in total

1.  Surgical management of early cervical cancer: the shape of future studies.

Authors:  Stefano Greggi; Cono Scaffa
Journal:  Curr Oncol Rep       Date:  2012-12       Impact factor: 5.075

2.  [S3 guidelines on diagnostics and treatment of cervical cancer: Demands on pathology].

Authors:  L-C Horn; M W Beckmann; M Follmann; M C Koch; P Mallmann; S Marnitz; D Schmidt
Journal:  Pathologe       Date:  2015-11       Impact factor: 1.011

3.  Pattern-based classification of invasive endocervical adenocarcinoma, depth of invasion measurement and distinction from adenocarcinoma in situ: interobserver variation among gynecologic pathologists.

Authors:  Carlos Parra-Herran; Monica Taljaard; Bojana Djordjevic; M Carolina Reyes; Lauren Schwartz; John K Schoolmeester; Ricardo R Lastra; Charles M Quick; Anna Laury; Golnar Rasty; Marisa R Nucci; Brooke E Howitt
Journal:  Mod Pathol       Date:  2016-05-13       Impact factor: 7.842

4.  Tumor volume and lymphovascular space invasion as a prognostic factor in early invasive adenocarcinoma of the cervix.

Authors:  Isao Murakami; Takuma Fujii; Kaori Kameyama; Takashi Iwata; Miyuki Saito; Kaneyuki Kubushiro; Daisuke Aoki
Journal:  J Gynecol Oncol       Date:  2012-07-02       Impact factor: 4.401

5.  Analysis of treatment modalities and prognosis on microinvasive cervical cancer: a 10-year cohort study in China.

Authors:  Qiuhong Qian; Jiaxin Yang; Dongyan Cao; Yan You; Jie Chen; Keng Shen
Journal:  J Gynecol Oncol       Date:  2014-06-18       Impact factor: 4.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.